» Articles » PMID: 31979395

Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Jan 26
PMID 31979395
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) have immunomodulatory and regenerative effects in many organs, including the kidney. Emerging evidence has shown that the trophic effects from MSCs are mainly mediated by the paracrine mechanism rather than the direct differentiation of MSCs into injured tissues. These secretomes from MSCs include cytokines, growth factors, chemokines and extracellular vesicles (EVs) containing microRNAs, mRNAs, and proteins. Many research studies have revealed that secretomes from MSCs have potential to ameliorate renal injury in renal disease models, including acute kidney injury and chronic kidney disease through a variety of mechanisms. These trophic mechanisms include immunomodulatory and regenerative effects. In addition, accumulating evidence has uncovered the specific factors and therapeutic mechanisms in MSC-derived EVs. In this article, we summarize the recent advances of immunomodulatory and regenerative effects of EVs from MSCs, especially focusing on the microRNAs.

Citing Articles

Frontier role of extracellular vesicles in kidney disease.

Li B, Qi C, Zhang Y, Shi L, Zhang J, Qian H J Nanobiotechnology. 2024; 22(1):583.

PMID: 39304945 PMC: 11414213. DOI: 10.1186/s12951-024-02852-3.


Advancements in diabetic foot ulcer research: Focus on mesenchymal stem cells and their exosomes.

Wu S, Zhou Z, Li Y, Jiang J Heliyon. 2024; 10(17):e37031.

PMID: 39286219 PMC: 11403009. DOI: 10.1016/j.heliyon.2024.e37031.


The Role of Dental-derived Stem Cell-based Therapy and Their Derived Extracellular Vesicles in Post-COVID-19 Syndrome-induced Tissue Damage.

Rostami M, Farahani P, Esmaelian S, Bahman Z, Hussein A, A Alrikabi H Stem Cell Rev Rep. 2024; 20(8):2062-2103.

PMID: 39150646 DOI: 10.1007/s12015-024-10770-y.


MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury.

Tsuji K, Nakanoh H, Fukushima K, Kitamura S, Wada J Diagnostics (Basel). 2023; 13(18).

PMID: 37761260 PMC: 10529274. DOI: 10.3390/diagnostics13182893.


Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances.

Zhang E, Phan P, Zhao Z Acta Pharm Sin B. 2023; 13(5):1789-1827.

PMID: 37250173 PMC: 10213819. DOI: 10.1016/j.apsb.2022.08.020.


References
1.
Lyu H, Li X, Wu Q, Hao L . Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα. J Pharmacol Sci. 2019; 141(1):70-78. DOI: 10.1016/j.jphs.2019.09.007. View

2.
Kim H, Choi D, Yun S, Choi S, Kang J, Jung J . Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2011; 11(2):839-49. DOI: 10.1021/pr200682z. View

3.
Bruno S, Tapparo M, Collino F, Chiabotto G, Deregibus M, Lindoso R . Renal Regenerative Potential of Different Extracellular Vesicle Populations Derived from Bone Marrow Mesenchymal Stromal Cells. Tissue Eng Part A. 2017; 23(21-22):1262-1273. PMC: 5689130. DOI: 10.1089/ten.TEA.2017.0069. View

4.
Hills C, Squires P . The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011; 22(3):131-9. DOI: 10.1016/j.cytogfr.2011.06.002. View

5.
Park J, Kato M, Lanting L, Castro N, Nam B, Wang M . Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions. Am J Physiol Renal Physiol. 2014; 307(12):F1390-403. PMC: 4269695. DOI: 10.1152/ajprenal.00458.2014. View